SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-006137
Filing Date
2023-01-11
Accepted
2023-01-11 09:00:34
Documents
14
Period of Report
2023-01-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d514174d8k.htm   iXBRL 8-K 41013
2 EX-3.1 d514174dex31.htm EX-3.1 6571
3 EX-3.2 d514174dex32.htm EX-3.2 62823
  Complete submission text file 0001193125-23-006137.txt   262697

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imgo-20230111.xsd EX-101.SCH 2842
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgo-20230111_lab.xml EX-101.LAB 19483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgo-20230111_pre.xml EX-101.PRE 12148
8 EXTRACTED XBRL INSTANCE DOCUMENT d514174d8k_htm.xml XML 3684
Mailing Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065
Business Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065 (415) 529-5055
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40604 | Film No.: 23522630
SIC: 2834 Pharmaceutical Preparations